Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Fingrut, MD, assistant professor of stem cell transplantation and cellular therapy at The University of Texas MD Anderson Cancer Center. Stem cell donations can be done in different ways ...

In a lab in the heart of Boston, professor Bree Aldridge leads a team of researchers trying to understand a threat that is ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

Explore GISTs, rare GI tumors. Discover key details on genetic causes, diagnostic methods, and cutting-edge treatment ...

Tumor-infiltrating clonal hematopoiesis (TI-CH) increased the risk of disease recurrence or death among patients with early ...

You’ve probably heard of the four stages of cancer—but there’s another even earlier stage that experts say can make a huge difference in treating the disease.

Some of these cancerous mutations in DNA are inherited, while others arise from errors that occur as a cell divides.

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ's dense tissue to define the margins between malignant and normal tissue. A new study uses DNA origami ...